Purpose: To examine the safety and effectiveness of the new large-bore Indigo thrombectomy catheters to treat patients with acute renovisceral occlusion without the need of thrombolytic agents. Methods: Between November 2015 and 2016, 7 consecutive patients (mean age 65±5 years; 5 men) with acute renovisceral artery occlusion were treated with the new large-bore (6-F and 8-F) vacuum-assisted thrombectomy catheters. The occluded vessels were 6 renal arteries and 3 superior mesenteric arteries (SMAs); 5 of the 9 thromboses were in bridging stent-grafts associated with branched endografts. Mean lesion length was 63±36 mm. For the SMA and all bridging stent-grafts, 8-F catheters are routinely used through a brachial access, whereas 6-F aspiration catheters were used in native renal arteries. Technical success was defined as restoration of antegrade blood flow without the need of lysis or alternative thrombectomy/revascularization strategies. Safety endpoints were any in-hospital major adverse events. Pre- and postoperative hemoglobin and hematocrit levels were compared. Results: Technical success was 100% with no major adverse events or fatal bleeding. The mean amount of aspirated blood was 219±97 mL. The mean hemoglobin and hematocrit values were 13.1±2.1 g/dL and 39%±6% prior to and 11.6±2.2 g/dL (p=0.001) and 34%±6% (p<0.0001) directly after the intervention, respectively. Conclusion: The first assessment of the new large-bore Indigo thrombectomy catheters showed them to be an effective and safe lysis-free frontline therapy for acute renovisceral artery occlusion in a small cohort of patients. New users should be fully aware of the potential blood loss during aspiration.
ClairDGBeachJM. Mesenteric ischemia. N Engl J Med. 2016;374:959–968.
2.
HowardDPBanerjeeAFairheadJF. Population-based study of incidence, risk factors, outcome and prognosis of ischemic peripheral arterial events. Circulation. 2015;132:1805–1815.
3.
KärkkäinenJMLehtimäkiTTManninenH. Acute mesenteric ischemia is a more common cause than expected of acute abdomen in the elderly. J Gastrointest Surg. 2015;19:1407–1414.
4.
AcostaSOgrenMSternbyNH. Incidence of acute thrombo-embolic occlusion of the superior mesenteric artery: a population-based study. Eur J Vasc Endovasc Surg. 2004;27:145–150.
5.
BisdasTDonasKPBosiersMJ. Custom-made versus off-the-shelf multibranched endografts for endovascular repair of thoracoabdominal aortic aneurysms. J Vasc Surg. 2014;60:1186–1195.
6.
ArthursZMTitusJBannazadehM. A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg. 2011;53:698–705.
7.
KärkkäinenJMLehtimäkiTTSaariP. Endovascular therapy as a primary revascularization modality in acute mesenteric ischemia. Cardiovasc Intervent Radiol. 2015;38:1119–1129.
8.
Penumbra Pivotal Stroke Trial Investigators. The Penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40:2761–2768.
9.
BaumannFSharpeEIIIPenaC. Technical results of vacuum-assisted thrombectomy for arterial clot removal in patients with acute limb ischemia. J Vasc Interv Radiol. 2016;27:330–335.
10.
KarnabatidisDSpiliopoulosSTsetisD. Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovasc Intervent Radiol. 2011;34:1123–1136.
11.
KhatriPNeffJBroderickJP. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke. 2005;36:2400–2403.
12.
MehranRRaoVSBhattDL. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736–2747.
13.
TeigenCL. Penumbra/Indigo System provides a novel aspiration thrombectomy tool in treatment of peripheral and visceral arterial occlusions—final results of the PRISM trial. Paper presented at: the annual Society of Interventional Radiology meeting; April 6, 2016; Vancouver, British Columbia, Canada.
14.
MorrowKLKimAHPlatoSA2nd. Increased risk of renal dysfunction with percutaneous mechanical thrombectomy compared with catheter-directed thrombolysis. J Vasc Surg. 2017;65:1460–1466.
15.
YamadaRAdamsJGuimaraesM. Advantages to Indigo mechanical thrombectomy for ALI: device and technique. J Cardiovasc Surg (Torino). 2015;56:393–400.
16.
SembC. Partial resection of the kidney: anatomical, physiological and clinical aspects. Ann R Coll Surg Engl. 1956;19:137–155.
17.
HamiltonPBPhillipsRAHillerA. Duration of renal ischemia required to produce uremia. Am J Physiol. 1948;152:517–522.
18.
HazanovNSominMAttaliM. Acute renal embolism. Forty-four cases of renal infarction in patients with atrial fibrillation. Medicine (Baltimore). 2004;83:292–299.
19.
ZanklARDenglerTJAndrassyM. Recovery of renal function after delayed percutaneous dilation of a subtotal in-stent restenosis of the renal artery in a left solitary kidney. NDT Plus. 2009;2:236–238.
20.
SiablisDLiatsikosENGoumenosD. Percutaneous rheolytic thrombectomy for treatment of acute renal-artery thrombosis. J Endourol. 2005;19:68–71.
21.
KellumJALameireN; KDIGO AKI Guideline Work Group. Diagnosis, evaluation and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.
22.
PanuccioGBisdasTBerekovenB. Performance of bridging stent grafts in fenestrated and branched aortic endografting. Eur J Vasc Endovasc Surg. 2015;50:60–70.
